Manufacturer profile
Sparsh Bio-Tech Pvt. Ltd., India
Every published regulatory action recorded against this manufacturer, across all African authorities Drug Eye Africa monitors. Built strictly from published regulatory decisions and nothing else.
What these numbers are. They are counts of published regulatory actions recorded on this register. They are not a finding about the company, not an allegation, and not a measure of product quality. A manufacturer appearing here has had actions published against named products by named authorities; the actions speak for themselves and each one links to its primary notice.
11
Recorded actions
2
Countries
2
Authorities
0
Class I actions recorded
| Reference | Date | Ctry | Product | Batches | Action | Class | Source |
|---|---|---|---|---|---|---|---|
| DEA-ZM-2026-63941389 | 07 Jan 2026 | ZM | Cloxispa-250 Cloxacillin Capsules BP 250mg Sparsh Bio-Tech Pvt. Ltd., India | CC315 | Recall | Unclassified | Tier 1 · Regulator-published |
| DEA-RW-2023-64950672 | 27 Jan 2023 | RW | Spamox oral suspension (amoxicillin 125 mg/ 5ml) Sparsh Bio- Tech Pvt Ltd/ India | none published | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2023-58422245 | 27 Jan 2023 | RW | Spamox oral suspension (amoxicillin 250 mg/ 5ml) Sparsh Bio- Tech Pvt Ltd/ India | none published | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2022-96999801 | 29 Apr 2022 | RW | Amoxicillin oral Suspension SPARSH BIO-TECH PVT Ltd/ INDIA | X0942 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2022-76520891 | 29 Apr 2022 | RW | Amoxicillin oral Suspension SPARSH BIO-TECH PVT Ltd/ INDIA | X0937 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2022-62003413 | 29 Apr 2022 | RW | Amoxicillin oral Suspension SPARSH BIO-TECH PVT Ltd/ INDIA | X0938 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2022-41086436 | 29 Apr 2022 | RW | Amoxicillin oral Suspension SPARSH BIO-TECH PVT Ltd/ INDIA | X0939 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2022-35707323 | 29 Apr 2022 | RW | Amoxicillin oral Suspension SPARSH BIO-TECH PVT Ltd/ INDIA | X0941 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2022-28564933 | 29 Apr 2022 | RW | Amoxicillin oral Suspension (SPAMOX) SPARSH BIO-TECH PVT Ltd/ INDIA | X0908 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2022-28509129 | 29 Apr 2022 | RW | Amoxicillin oral Suspension SPARSH BIO-TECH PVT Ltd/ INDIA | X0940 | Recall | Class II | Tier 1 · Regulator-published |
| DEA-RW-2022-10399040 | 29 Apr 2022 | RW | Amoxicillin oral Suspension (spamox) SPARSH BIO-TECH PVT Ltd/ INDIA | X0934 | Recall | Class II | Tier 1 · Regulator-published |
Counts are of published regulatory actions recorded on this register. They are not a finding about the company, and this page says so.
Names as published
This profile groups 3 spellings used by the issuing authorities: Sparsh Bio-Tech Pvt. Ltd., India; Sparsh Bio- Tech Pvt Ltd/ India; SPARSH BIO-TECH PVT Ltd/ INDIA.
Company response
No response filed. Any named company may register and publish a reply beside these records, and the invitation is logged whether or not it is answered.
How this page is built
- Published regulator decisions only — no press reports, no allegations
- Name matching is conservative: only corporate-form suffixes are stripped, and a name that would reduce to a single token is kept whole
- Every action links to its primary notice